Client Relationships
Endocrinology & Metabolic Diseases
Explore best practices and techniques in endocrinology and metabolic diseases for your veterinary practice.
This study examined use of canagliflozin, a sodium-glucose cotransporter-2 inhibitor, in dogs with diabetes mellitus.
New in Endocrinology & Metabolic Diseases
More in Endocrinology & Metabolic Diseases
Sponsored byBoehringer Ingelheim